RadNet, Inc. · NASDAQ:RDNT
RadNet — Investor Presentation (September 2012)
22 slides from RadNet's investor presentation, September 2012
Slide 1: RadNet Investor Presentation September 2012
September 2012 NASDAQ: RDNT (BADNETin A premier network of centers providing diagnostic radiology and imaging services
Slide 2: Safe Harbor
Safe Harbor This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning RadNet’ s ability to continue to grow the business by generating patient referrals and contracts with radiology pract
Slide 3: Introduction
I. Introduction II. Diagnostic Imaging Industry Overview III. Overview of RadNet IV. Financial Information and Core Strategy 2
Slide 4: RadNet Summary
RadNet Summary Largest national owner and operator of fixed-site diagnostic imaging centers, with 237 locations Founded as a one center CA operation in 1980 Largest fixed-site diagnostic imaging center company in U.S.; over 2x next largest player Fastest growing consolidator in the highly fr
Slide 5: RadNet Summary (cont.)
RadNet Summary (cont.) Emphasis placed on scale and multi-modality strategy “ One-stop-shopping”for referral sources Lessens our exposure to reimbursement changes, diversifies revenue base Regional clustering, multi-modality strategy and scale make us better equipped to negotiate fair and st
Slide 6: Types of Imaging Exams: Modalities
Types of Imaging Exams: “Modalities” “Advanced Imaging” “Routine Imaging” MRI –Produces high Nuclear Medicine – resolution cross- Producers images of sectional images of soft anatomical structures. tissue. Applications: Applications: Assesses brain, spinal cord and organ function in heart, interior
Slide 7: Diagnostic Imaging Industry Overview
I. Introduction II. Diagnostic Imaging Industry Overview III. Overview of RadNet IV. Financial Information and Core Strategy 6
Slide 8: Diagnostic Imaging: A Large and Growing Market
Diagnostic Imaging: A Large and Growing Market National imaging market is estimated to be over $100 billion Approximately 80% of industry procedural volume is “ routine imaging”(x-ray, ultrasound, mammo, etc.) Approximately 20% is “ advanced imaging”(MRI, CT, PET/CT) Industry remains highly
Slide 9: Industry is Currently Under Pressure
Industry is Currently Under Pressure Volumes during this economic slowdown have been challenged for the first time in decades Visits to primary care and specialist physicians are down in last 24 months CT volumes are challenged by concerns over radiation exposure Mammo volumes have been affe
Slide 10: Scale is Becoming Vital for Success; Industry Consolidation Has Begun
Scale is Becoming Vital for Success; Industry Consolidation and Rationalization has Begun “ Mom-and-pop”operators are struggling Not well capitalized and have a higher cost structure Single-modality facilities that are more impacted by reimbursement changes and competition from multi-modality
Slide 11: Overview of RadNet
I. Introduction II. Diagnostic Imaging Industry Overview III. Overview of RadNet IV. Financial Information and Core Strategy 10
Slide 12: Strong Regional Presence Enables Scale and Leverage Over Competitors
Strong Regional Presence Enables Scale and Leverage Over Competitors 30-year operating track record; Consolidator in the highly fragmented imaging industry 237 diagnostic imaging facilities in concentrated markets of CA, MD, DE, NJ, RI, NY and FL Vast majority of facilities are multi-modality
Slide 13: Favorable Revenue Mix Mitigates Reimbursement Risk
Favorable Revenue Mix Mitigates Reimbursement Risk Emphasis placed on multi-modality strategy “ One-stop-shopping”for referral sources Lessens exposure to reimbursement changes, diversifies revenue base Extensive offering of all routine imaging procedures partially insulates us from reimburs
Slide 14: Strong and Diversified Payor Mix
Strong and Diversified Payor Mix Strong payor relationships –RadNet is a critical provider of diagnostic imaging solutions to healthcare insurance providers Payor diversity mitigates exposure to possible unfavorable reimbursement trends within any one payor class Exclusive capitation business
Slide 15: Capitated Contracts Create a Barrier to Entry
Capitated Contracts Create a Barrier to Entry RadNet has over 25 capitated contracts with California physician groups representing approximately 15% of our revenue We receive a per-member-per-month fixed price for exclusively providing outpatient imaging to over 750,000 lives in CA Exclusive n
Slide 16: Recent Diversification: Breast Disease Management, Radiology Software & Teleradiology
Recent Diversification: Breast Disease Management, Radiology Software & Teleradiology In 2008, we acquired renowned specialty breast medical oncology and breast surgery practices in Southern California (“ BreastLink” ) Expanded into other areas of Orange County, Temecula, Palm Springs and San Fe
Slide 17: Recent Diversification: Breast Disease Management, Radiology Software & Teleradiology
Recent Diversification: Breast Disease Management, Radiology Software & Teleradiology On January 3, 2011, we acquired Imaging on Call, a Poughkeepsie, New York, provider of preliminary and final remote radiology interpretation Services hospital-based radiology groups, hospitals and imaging cente
Slide 18: Experienced Management Team
Experienced Management Team Howard Berger, MD –Chairman and Chief Executive Officer Mark Stolper –Chief Financial Officer Co-founded RadNet in 1981 Deep experience in investment banking and private Over 25 years of experience in the equity development and management of Dillon Read investment ban
Slide 19: Financial Information and Core Strategy
I. Introduction II. Diagnostic Imaging Industry Overview III. Overview of RadNet IV. Financial Information and Core Strategy 18
Slide 20: Proven Track Record of EBITDA Growth and Cash Flow Generation
Proven Track Record of EBITDA Growth and Cash Flow Generation RadNet has a consistent track record of achieving profitable growth and generating significant cash flow Procedure Volumes Net Revenue 3,749 (Procedures in Thousands) 3,315 $700 3,600 3,174 $620 ($ in millions) 2,900 2,710 $600 $549 2,337
Slide 21: Strong Year-to-Date Performance in a Difficult Operating Environment
Strong Year-to-Date Performance in a Difficult Operating Environment 6 Mo Revenue was $340.2 million vs. $297.5 million in 2011, growth of 14.4% 6 Mo EBITDA was $60.5 vs. $56.2 in 2011, growth of 7.6% Q1 same-center volumes increased 5.8%, Q2 same-center volumes increased 0.8% Trailing twelv
Slide 22: Summary Valuation Metrics: RDNT
Summary Valuation Metrics: RDNT EBITDA Valuation Metrics 1 Equity Market Capitalization @ $2.73 per share $ 104.7 mm 2 Net Debt 553.7 mm Current Enterprise Valuation $ 658.4 mm Trailing 12 Mo. EBITDA - 3/31/2012 $ 119.8 mm Midpoint of 2012 EBITDA Guidance $ 125.0 mm Enterprise Value / Trailing 12 Mo